Inactive Instrument
Sector dividends InterMune Inc
Stocks
US45884X1037
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 0 | ||
| 1.11% | 1.27% | 29.6x | 3.79x | 5.25x | 16.28x | 22.85x | 43.03B | ||
| -.--% | -.--% | -19.35x | 14.12x | 285.46x | -17.58x | -17.28x | 32.71B | ||
| -.--% | -.--% | 22.08x | 4.18x | 2.54x | 10.99x | 16.75x | 30.29B | ||
| -.--% | -.--% | 39.46x | 5.89x | 3.91x | 25.05x | 29.65x | 29.4B | ||
| 0.4% | 0.41% | 29.23x | 2.18x | 7.53x | 19.36x | 23.11x | 25.08B | ||
| -.--% | -.--% | 27.43x | 13.74x | 4.4x | 20.02x | 20.99x | 13.35B | ||
| 1.2% | 1.4% | 22.25x | 2.33x | 1.93x | 8.48x | 13.43x | 12.97B | ||
| -.--% | -.--% | -20.3x | 302.63x | 13.35x | -19.88x | -19.33x | 12.11B | ||
| -.--% | -.--% | 23.26x | 1.14x | 1.68x | 10.17x | 11.65x | 11.19B | ||
| -.--% | -.--% | 30.57x | 2.74x | 2.81x | 10.99x | 13.33x | 9.03B | ||
| -.--% | -.--% | -23.75x | 21.19x | 5.79x | 142.09x | -447.16x | 8.59B | ||
| 0.59% | 0.59% | 46.31x | 3.92x | 6.94x | 19.67x | 21.64x | 8.45B | ||
| -.--% | -.--% | -22.11x | 38.43x | 1676.77x | -23.91x | -24.51x | 7.85B | ||
| -.--% | 0.51% | 17.68x | 2.01x | 3.8x | 10.12x | 12.96x | 7.66B | ||
| -.--% | -.--% | -17.51x | 6.64x | 1535.11x | -14.49x | -13.76x | 7.43B | ||
| -.--% | -.--% | -111.54x | 4x | 4.61x | 24.42x | 146.52x | 7.38B | ||
| Average | 0.21% | 0.26% | 4.58x | 26.81x | 222.62x | 15.11x | -11.82x | 15.68B | |
| Weighted average by Cap. | 0.29% | 0.34% | 12.55x | 20.66x | 131.22x | 12.68x | 0.29x |
- Stock Market
- Stocks
- Stock
- Sector InterMune Inc
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















